Combining Ruxolitinib With Donor Regulatory T Cells May Outperform Monotherapy in Chronic Graft Vs Host Disease
Researchers sought to determine whether combining ruxolitinib with donor regulatory T cells would improve outcomes of cGVHD.
General Hematology
Discordance in Symptomatic Adverse Event Reports by Clinicians, Children in Cancer Clinical Trials
An observational study sought to compare the perceptions of symptom burden in childhood cancer by children, clinicians, and caregivers.
Donor Sex, Parity Do Not Up Mortality for Red Blood Cell Recipients
After adjustment for donor hemoglobin levels, no increased risk seen for requiring additional transfusion after transfusion from female donor.
HCVAD Induced High Response Rates in Blastic Plasmacytoid Dendritic Cell Neoplasm
Researchers sought to evaluate the outcomes of patients with BPDCN treated with HCVAD.
Patients With Polycythemia Vera Achieve Long-Term Treatment Goals With Ropeginterferon Alfa-2b
Researchers sought to determine whether long-term ropeginterferon alfa-2b would have benefits in patients with PV compared with hydroxyurea or the best available treatment.
Evusheld Appears Less Effective Against Omicron for Patients With Blood Cancer
A single 150 mg dose of Evusheld demonstrated neutralizing activity against wild-type SARS-CoV-2 but not the omicron variant.
U.S. Spends More on Cancer Than Other Countries, but Without Mortality Benefit
U.S. had the highest per capita spending on cancer care in 2020, but a median cancer mortality rate.
Patient-Reported Outcomes and Overall Survival After Allogeneic Hematopoietic Stem Cell Transplantation
Researchers sought to find whether there was a relationship between patient-reported outcomes and overall survival after hematopoietic stem cell transplantation.
Momelotinib Bests Danazol in Symptomatic, Anemic Myelofibrosis
Momelotinib proved superior to danazol in patients with symptomatic, anemic myelofibrosis in a phase 3 study.
Radiomics: An Emerging Frontier in Cancer Diagnostics, Treatment Planning
This overview of radiomics explains its potential for improving diagnosis, predictions of tumor response and recurrence, and patient prognosis.
- Loading...
Loading...
Next post in General Hematology
Loading... 
Loading...